Schedule 13G ownership disclosure

ADAPTIVE BIOTECHNOLOGIES CORP

Common stock, par value $0.0001 per share · CUSIP: 00650F109

Event date: 2024-12-31

Filing-level shares
6,833,137
Percent of class
4.63%
  • Nikko Asset Management Americas, Inc.

    Shares: 6,833,137 · Class: 4.63%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-25-004241
Form type
SCHEDULE 13G/A
Filer
Adaptive Biotechnologies Corp
CIK
CIK 1478320
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub